21 CFR Part 56 covers which regulatory topic?

21 CFR Part 56 covers which regulatory topic?

• A. Part 210
• B. Part 50
• C. Part 56
• D. Part 820

Answer: (C)

The main concept is Institutional Review Boards and their role in protecting people who participate in FDA-regulated research. 21 CFR Part 56 sets the requirements for IRBs—their composition, authority, and responsibilities; how they review and approve studies; when continuing review is needed; and the records they must keep. This framework ensures that risks to subjects are minimized and that the rights and welfare of participants are protected throughout a study. Part 56 works alongside Part 50, which covers informed consent, by requiring the IRB to review and approve consent processes and documents as part of ethical oversight. It’s distinct from other parts that govern manufacturing practices or device quality systems, such as Part 210 for drug GMPs and Part 820 for medical device quality systems. In short, Part 56 is about IRBs and human subject protection in FDA-regulated research.

The main concept is Institutional Review Boards and their role in protecting people who participate in FDA-regulated research. 21 CFR Part 56 sets the requirements for IRBs—their composition, authority, and responsibilities; how they review and approve studies; when continuing review is needed; and the records they must keep. This framework ensures that risks to subjects are minimized and that the rights and welfare of participants are protected throughout a study. Part 56 works alongside Part 50, which covers informed consent, by requiring the IRB to review and approve consent processes and documents as part of ethical oversight. It’s distinct from other parts that govern manufacturing practices or device quality systems, such as Part 210 for drug GMPs and Part 820 for medical device quality systems. In short, Part 56 is about IRBs and human subject protection in FDA-regulated research.